Whole-tumoral metabolic heterogeneity in 18F-FDG PET/CT is a novel prognostic marker for neuroblastoma

Whole-tumoral metabolic heterogeneity in 18F-FDG PET/CT is a novel prognostic marker for neuroblastoma

Abstract Background Neuroblastoma (NB) is a highly heterogeneous tumor, and more than half of newly diagnosed NB are associated with extensive metastases. Accurately characterizing the heterogeneity of whole-body tumor lesions remains clinical challenge. This study aims to quantify whole-tumoral met...

Full description

Bibliographic Details
Main Authors: Jun Liu, Qinghua Ren, Haonan Xiao, Siqi Li, Lingling Zheng, Xu Yang, Lijuan Feng, Ziang Zhou, Huanmin Wang, Jigang Yang, Wei Wang
Format: Article
Language:English
Published: BMC 2024-06-01
Series:Cancer Imaging
Subjects:
Neuroblastoma
Whole-tumoral metabolic heterogeneity
Intra-tumoral metabolic heterogeneity
18F-FDG PET/CT
Prognosis
Online Access:https://doi.org/10.1186/s40644-024-00718-3

Internet

https://doi.org/10.1186/s40644-024-00718-3

Similar Items